RapidAI Rakes In $75M to Accelerate Stroke Diagnosis

RapidAI secured a $75 million Series C funding round led by Vista Credit Partners, highlighting the demand for its AI platform in accelerating stroke diagnosis. Founded in 2012, the San Mateo-based company aids hospitals in managing high imaging volumes, addressing coordination challenges in vascular and neurointerventional care. RapidAI's technology, designed for fast disease diagnoses, saves critical time in acute situations, improving patient outcomes. The platform, deployed in over 2,200 hospitals across 100 countries, employs algorithms for quick image analysis. CEO Karim Karti emphasizes its clinical depth, validated by over 320 publications and 25 clinical trials, setting it apart in the competitive healthcare AI space. RapidAI envisions further expansion into managing additional diseases.